- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Marlborough Today
By the People, for the People
Rhenman & Partners Asset Management AB Boosts Boston Scientific Holdings
Institutional investor increases stake in medical device company by 48% in Q3
Published on Mar. 8, 2026
Got story updates? Submit your updates here. ›
Rhenman & Partners Asset Management AB, an institutional investor, grew its holdings in Boston Scientific Corporation (NYSE:BSX) by 48% in the third quarter, according to a recent SEC filing. The firm now owns 438,000 shares of the medical equipment provider's stock, valued at $42.76 million, making it one of Boston Scientific's largest shareholders.
Why it matters
This increase in ownership by Rhenman & Partners Asset Management AB signals confidence in Boston Scientific's growth prospects and the firm's belief in the company's long-term potential. As a major institutional investor, Rhenman's actions can influence market sentiment and potentially impact Boston Scientific's stock price.
The details
According to the SEC filing, Rhenman & Partners Asset Management AB acquired an additional 142,000 shares of Boston Scientific in the third quarter, bringing its total holdings to 438,000 shares. This represents approximately 4.7% of the firm's total investment portfolio, making Boston Scientific its largest holding.
- Rhenman & Partners Asset Management AB increased its Boston Scientific holdings in the 3rd quarter of 2026.
The players
Rhenman & Partners Asset Management AB
An institutional investor that manages a portfolio of investments, including a significant stake in Boston Scientific Corporation.
Boston Scientific Corporation
A global medical device company that develops, manufactures, and markets a broad portfolio of products used in less-invasive medical procedures.
The takeaway
Rhenman & Partners Asset Management AB's increased stake in Boston Scientific suggests the firm sees significant upside potential in the medical device company. This move highlights the confidence institutional investors have in Boston Scientific's ability to drive long-term growth and shareholder value.
